| Hoffmann-La Roche: Pricing the Zelboraf Melanoma Treatment for Canada - Teaching Note |
| 作者姓名：Mark Zbaracki; Jedy Wang |
| 商品類型： | 商品編號：8B16M138 |
| 出版日期：2016/12/09 | 內容長度：11 頁 |
Teaching note for product 9B16M138.
|
| Hoffmann-La Roche: Pricing the Zelboraf Melanoma Treatment for Canada |
| 作者姓名：Mark Zbaracki; Jedy Wang; |
| 商品類型：Case (Pub Mat) | 商品編號：9B16M138 |
| 出版日期：2016/09/12 | 內容長度：12 頁 |
The Canadian brand manager of Zelboraf had to decide how to introduce and price Zelboraf in the Canadian market. Zelboraf was a breakthrough discovery in treatment for melanoma cancer patients. Hoffmann-La Roche (Roche) began developing Zelboraf in 2005. During the clinical trials, the drug yielded such positive results in targeting late-stage (metastatic) melanoma cancer that Roche ended clinical trials early in order to expedite FDA approval and .....more
|